Search results
Alvotech and Teva’s Selarsdi™ (ustekinumab-aekn), Biosimilar to Stelara® Approved by FDA | JD Supra
JD Supra· 18 hours agoThe companies announced in June 2023 that they had reached a settlement and license agreement with Johnson & Johnson, which granted a license entry date for Selarsdi™ in the U.S. by February ...
Pharma Stock Roundup: JNJ's Q1 Results, LLY, ABBV, RHHBY's Successful Study Data
Zacks via Yahoo Finance· 5 days agoJ&J Begins Q1 Earnings Season: J&J’s first-quarter results were mixed as it beat estimates for...
How Is Ulcerative Colitis Treated?
Health via Yahoo News· 6 days agoIntegrin receptor agonists: Tysabri (natalizumab) and Entyvio (vedolizumab) prevent inflammatory cells from moving into the intestinal lining by blocking a protein on the cells' surfaces. Anti-interleukin ...
Stock Market Sells Off; Taiwan Semi, ASML, Netflix, Tesla In Focus: Weekly Review
Investor's Business Daily· 5 days agoAbbott's EPS declined 5%, while J&J's rose 12%. Abbott beat sales forecasts, but issued light...
What Are the Most Effective Psoriasis Therapy Options?
Verywell Health via Yahoo News· 24 hours agoWith many treatment options for psoriasis, how do you know which ones are right for you? Here are...
Analyst updates Johnson & Johnson stock price target after earnings
TheStreet via Yahoo Finance· 5 days ago“While sequential growth was roughly flat due to phasing, we continue to anticipate...
5 Crash-Proof Stocks to Buy Immediately
InvestorPlace· 3 days agoIn February, I recommended five one-month momentum plays to buy as Bitcoin (BTC-USD) prices surged. The world’s largest cryptocurrency is a surprisingly...
What’s Next For Johnson & Johnson Stock After Beating Q1 Earnings?
Forbes· 6 days agoJohnson & Johnson (NYSE: JNJ) recently reported its Q1 results, with revenues marginally below but...
FDA requires changes to CAR-T cell therapy boxed warning (NYSE:BMY)
Seeking Alpha· 6 days agoThe FDA has mandated updates to safety information for CAR-T cell therapies due to a severe risk of...
The Zacks Analyst Blog Highlights NVIDIA, Alphabet, Johnson & Johnson, Broadridge Financial and...
Zacks via Yahoo Finance· 6 days agoPer the Zacks analyst, headwinds like generic competition and pricing pressure continue to ail. The...